Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Diosynth To Manufacture Viron's ACS Candidate | Contract Pharma

What are you searching for?

Sign in
Breaking News

Diosynth To Manufacture Viron’s ACS Candidate

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Viron Therapeutics, Inc. has signed an agreement with Diosynth Biotechnology for process development, scale-up, and clinical manufacturing for its lead product candidate, VT-111, currently in Phase II trials for the treatment of inflammation associated with Acute Coronary Syndrome (ACS).

“We are very pleased to be working with Viron,” said Frank Tielens, president of Diosynth Biotechnology. “Our experience in technology transfer, in process development and in cGMP production and our regulatory history have certainly been noticed and appreciated by the industry.” Mr. Tielens added, “Because of these strengths, we have been rewarded with innovative customers such as Viron whose VT-111 product was recently identified as one the 10 most promising cardiovascular drug candidates in development.”

“We have entrusted Diosynth with the clinical manufacturing of our lead drug candidate, VT-111, as they have proven themselves to be world leaders in this area,” stated Neil K. Warma, president and chief executive officer of Viron. “The manufacturing process developed will ultimately support pivotal trials and the eventual market launch of VT-111, which is currently being tested in a multi-center Phase II trial, and we are pleased to have such a strong partner in Diosynth,” added Mr. Warma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics